Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 2050 of 3173 entries
View as:

CP-690,550 Pharmacokinetics In Healthy Chinese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01101919 Org: User:
Start: 10/31/10 End: 10/31/10 Due: 10/31/11

A Study to Learn How Different Forms of The Study Medicine Called Phenytoin Are Taken up Into the Blood in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT06466473 Org: User:
Start: 07/03/24 End: 10/04/24 Due: 10/04/25

A Pilot Study Of Smoking Cessation Treatment Including Varenicline In Patients Scheduled For Planned Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00889720 Org: User:
Start: 11/30/09 End: 07/31/10 Due: 07/31/11

Study the Effects of Different Doses of UK-369,003 in Men With Lower Urinary Tract Symptoms.

Phase: N/A Priority: Normal
NCT ID: NCT00457457 Org: User:
Start: 05/31/07 End: 04/30/08 Due: 04/30/09

A Study to Learn About a Repeat 5-Day Treatment With the Study Medicines (Called Nirmatrelvir/Ritonavir) in People 12 Years Old or Older With Return of COVID-19 Symptoms and SARS-CoV-2 Positivity After Finishing Treatment With Nirmatrelvir/Ritonavir

Phase: N/A Priority: Normal
NCT ID: NCT05567952 Org: User:
Start: 10/19/22 End: 02/09/24 Due: 02/09/25

A Study to Understand the Effect of Low-Fat and High-Fat Meals on the Medicine Called PF-07284890 in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT05349864 Org: User:
Start: 06/17/22 End: 09/16/22 Due: 09/16/23

The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials

Phase: N/A Priority: Normal
NCT ID: NCT05203172 Org: User:
Start: 07/05/22 End: 12/31/26 Due: 12/31/27

The Effects of Fx-1006A on Transthyretin Stabilization and Clinical Outcome Measures in Patients With Non-V30M Transthyretin Amyloidosis

Phase: N/A Priority: Normal
NCT ID: NCT00630864 Org: User:
Start: 06/30/08 End: 01/31/10 Due: 01/31/11

Continuing Access to Axitinib (A406- AG- 013736 ) For Patients Previously Receiving AG 013736 In Clinical Trials

Phase: N/A Priority: Normal
NCT ID: NCT00828919 Org: User:
Start: 03/07/03 End: 08/14/23 Due: 08/14/24

[S,S]-Reboxetine Long Term Safety Study In Post-Shingles Pain.

Phase: N/A Priority: Normal
NCT ID: NCT00354094 Org: User:
Start: 11/30/06 End: 10/31/07 Due: 10/31/08

A Long Term Study To Evaluate The Safety, Tolerability And Efficacy Of CP-690,550 In Patients With Moderate To Severe Plaque Psoriasis And/Or Psoriatic Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01519089 Org: User:
Start: 03/31/12 End: 01/31/14 Due: 01/31/15

Xeljanz Special Investigation for Long-term Use in UC Patients

Phase: N/A Priority: Normal
NCT ID: NCT03643211 Org: User:
Start: 06/08/18 End: 11/10/22 Due: 11/10/23

Follow-Up Study for Exubera

Phase: N/A Priority: Normal
NCT ID: NCT00734591 Org: User:
Start: 08/31/08 End: 01/31/12 Due: 01/31/13

Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections

Phase: N/A Priority: Normal
NCT ID: NCT01499277 Org: User:
Start: 05/31/12 End: 01/31/15 Due: 01/31/16

A 52-Week Open-Label Safety Study of PD 0332334 in Subjects With Generalized Anxiety Disorder (GAD)

Phase: N/A Priority: Normal
NCT ID: NCT00735267 Org: User:
Start: 10/31/08 End: 04/30/09 Due: 04/30/10

A Study to Learn About the Effects of Medicines That Help in Thinning the Blood in People With Atrial Fibrillation (AF) Between 2016 and 2020 in France

Phase: N/A Priority: Normal
NCT ID: NCT05838664 Org: User:
Start: 07/07/23 End: 03/31/24 Due: 03/31/25

Open, Non Comparative Study Of Voriconazole In Slovak Patients With Very High Risk Of Developing An Invasive Fungal Infection

Phase: N/A Priority: Normal
NCT ID: NCT01137292 Org: User:
Start: 04/30/07 End: 11/30/09 Due: 11/30/10

A Phase I Study to Assess Novel Ointment in a Psoriasis Plaque Test

Phase: N/A Priority: Normal
NCT ID: NCT00762658 Org: User:
Start: 11/30/07 End: 12/07/07 Due: 12/07/08

Real-World Study of Ceftazidime Avibactam in China

Phase: N/A Priority: Normal
NCT ID: NCT05487586 Org: User:
Start: 10/20/22 End: 07/11/24 Due: 07/11/25

A Study To Describe The Use Of Tofacitinib After Use Of Rituximab In Patients With Rheumatoid Arthritis In A Real-World Setting

Phase: N/A Priority: Normal
NCT ID: NCT05487703 Org: User:
Start: 11/14/22 End: 12/23/22 Due: 12/23/23

Efficacy, Safety And Tolerability Of PF-06743649 In Gout Subjects.

Phase: N/A Priority: Normal
NCT ID: NCT02187029 Org: User:
Start: 07/31/14 End: 12/31/14 Due: 12/31/15

A Study To Investigate The Clearance Of PF-04776548 From The Body Following A Very Low (Micro) Dose Of The Compound Using A Low Level Of Radiotracer To Help Quantify Expected Low Concentrations Of PF-04776548 In The Body

Phase: N/A Priority: Normal
NCT ID: NCT01045317 Org: User:
Start: 01/31/10 End: 02/28/10 Due: 02/28/11

A Study Of PF-05190457 In Healthy Volunteers And Type-2 Diabetic Patients

Phase: N/A Priority: Normal
NCT ID: NCT01372163 Org: User:
Start: 07/31/11 End: 04/30/12 Due: 04/30/13

A Study Evaluating PF-03084014 In Patients With Advanced Breast Cancer With Or Without Notch Alterations

Phase: N/A Priority: Normal
NCT ID: NCT02299635 Org: User:
Start: 02/03/15 End: 01/14/16 Due: 01/14/17

A Study of SU11248 In Patients With Metastatic Breast Cancer Who Have Failed Selected Other Therapies.

Phase: N/A Priority: Normal
NCT ID: NCT00078000 Org: User:
Start: 03/31/04 End: 11/30/05 Due: 11/30/06